Attenuating bone loss in osteoporosis: the potential of corylin (CL) as a therapeutic agent

Song Zhou; Junming Huang; Kun Chen; Qixuan Wang; Zheng Liu; Yanli Sun; Feng Yin; Shanjin Wang; Zhiying Pang; Min Ma

doi:doi:10.18632/aging.205885

← Back

Research Paper Volume 16, Issue 11 pp 9569—9583

Attenuating bone loss in osteoporosis: the potential of corylin (CL) as a therapeutic agent

Figure 4. Inhibition of pre-osteoclast migration and fusion by CL. (A) The crystal violet staining image from pre-osteoclast treated with CL. (B) The number quantifying of migrated cells. (C) The analysis of the relative mRNA levels of OC-STAMP, DC-STAMP, and ATPv0d6. ^**P < 0.01; ^***P < 0.001; ^****P < 0.0001.